Johns Hopkins Presents Two Live CME Programs on Melanoma and Lung Cancer Live Online Wednesday October 12th at Oncology Care Live

Virtual Medical Education Presented by Johns Hopkins Streams Live at www.OncologyCareLive.com 

Two live continuing medical education (CME) programs covering the treatment of melanoma and lung cancer will be presented by the Johns Hopkins University School of Medicine live Wednesday October 12th at www.OncologyCareLive.com. These medical educational programs, which feature faculty from respected teaching hospitals such as Dana Farber, John Wayne Cancer Institute, Johns Hopkins, Memorial Sloan-Kettering and Mount Sinai presenting live via video, offer a total of 8 AMA PRA Category 1 Credits™. Video programming on hematology oncology topics also is available on demand at Oncology Care Live.

Live programming will begin at 9:00 AM EDT with four 1-hour sessions in “New Frontiers in Melanoma Management” supported by an educational grant from Merck & Co. From 1:00 to 5:00 PM EDT the educational summit, “Entering an Era of More Personalized Treatment in Lung Cancer: Increasing Patient Survival Rates”, supported by educational grants from Boehringer Ingelheim Pharmaceuticals, OSI Pharmaceuticals, Inc and Daiichi Sankyo, will stream live online.

Johns Hopkins University School of Medicine enables oncologists and other cancer care specialists to stay current on the latest science and treatment protocols by participating in streaming video presentations online from the convenience of any computer, through its programs at Oncology Care Live. There are no costs and no prerequisites to register and attend these programs. The agenda for Wednesday, October 12th at www.OncologyCareLive includes: 

New Frontiers in Melanoma Management

9:00 AM EDT           Targeted Therapy and Chemotherapy in Advanced Melanoma

Moderator:              Leslie A. Fecher, MD, University of Pennsylvania

Discussant:              Paul Chapman, MD, Memorial Sloan-Kettering

10:00 AM EDT         Questions in the Surgical Management of Melanoma

Moderator:              Lisa K. Jacobs, MD, Johns Hopkins University School of Medicine

Discussant:              Donald M. Morton, MD, John Wayne Cancer Institute

11:00 AM EDT         Immunotherapy in Patients with High Risk and Advanced Melanoma

Moderator:              William Sharfman, MD, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine

Discussant:              Howard L. Kaufman, MD, Rush University Cancer Center

12:00 PM EDT         Future Directions in Melanoma Therapy-Round Table Discussion

Moderator:              Evan Lipson, MD, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine

Discussants:            William Sharfman, MD, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine

                                Howard L. Kaufman, MD, Rush University Cancer Center

Entering an Era of More Personalized Treatment in Lung Cancer: Increasing Patient Survival Rates

1:00 PM EDT           Are We Ready to Move to Annual Screening for Lung Cancer in High Risk Patients?

Moderator:              Mark G. Kris, MD, Memorial Sloan-Kettering Cancer Center

Discussant:              Claudia I. Henschke, MD, Mount Sinai Medical Center

2:00 PM EDT           Recent Developments in Targeted Therapy for NSCLC

Moderator:              Mark G. Kris, MD, Memorial Sloan-Kettering Cancer Center

Discussant:              David M. Jackman, MD, Dana-Farber Cancer Institute

3:00 PM EDT           Application of Advancements in Biomarker Identification to Clinical Practice in Patients with NSCLC. Is it Ready for Primetime?

Moderator:              David S. Ettinger, MD, Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine

Discussant:              Peter Illei, MD, Johns Hopkins Bayview Medical Center

4:00 PM EDT           Optimizing Therapy Choices in Patients with SCLC

Moderator:              David S. Ettinger, MD, Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine

Discussants:            Jeffrey Crawford, MD, Duke University School of Medicine

ABOUT ONCOLOGY CARE LIVE

Oncology Care Live, the world’s largest online oncology congress, is presented by the Johns Hopkins University School of Medicine and produced by PlatformQ. Oncology Care Live enables oncologists, hematology oncologists and other healthcare practitioners specializing in the diagnosis, treatment and care of cancer patients to learn, connect and interact in real time. Johns Hopkins University offers Continuing Medical Education (CME) at no cost at www.OncologyCareLive.com, providing high quality learning opportunities which feature video presentations and panel discussions and real-time interactive Q&A all from the convenience of a computer.

Oncology Care Live and PlatformQ are trademarks of PlatformQ, LLC. All other trademarks or service marks are property of their respective owners.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS
New Frontiers in Melanoma Management

The Johns Hopkins University School of Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Entering an Era of More Personalized Treatment in Lung Cancer: Increasing Patient Survival Rates

The Johns Hopkins University School of Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDITS
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 4 hours of Category 1 credit for completing these programs.

DATE OF RELEASE/EXPIRATION

Live sessions will be available October 12, 2011 from 9:00 AM-5:00 PM (EDT). These presentations will be on-demand from October 13, 2011 to April 12, 2012 at www.OncologyCareLive.com.

LEARNING OBJECTIVES

New Frontiers in Melanoma Management

After participating in this activity, the participant will demonstrate the ability to:

• Identify current approaches to the surgical management of melanoma.
• Discuss the evaluation and development of biomarkers for diagnosis, staging and treatment of melanoma.
• Describe current recommended clinical practice for excision of localized melanomas and patient selection for sentinel lymph node biopsy.
• Identify novel agents and combination systemic therapies of melanoma currently being evaluated in clinical trials.
• Explain current approaches to the surgical management of melanoma.

Entering an Era of More Personalized Treatment in Lung Cancer: Increasing Patient Survival Rates

After participating in this activity, the participant will demonstrate the ability to:

• Practice early diagnosis of lung cancer so that patients may be found at less advanced, more treatable stages of the disease.
• Explain the importance of biomarkers that affect therapeutic efficacy so that patients most likely to benefit from a particular therapy can be identified.
• Identify targeted therapies available for the treatment of NSCLC and when and how to integrate them in combination with chemotherapy.
• Discuss current research data on treatment options for patients with SCLC.

TARGET AUDIENCE

Medical oncologists, hematologist/oncologists, surgical oncologists, dermatologists, radiation oncologists, pulmonologists, oncology nurses, advanced practice nurses and other healthcare professionals who care for melanoma and/or lung cancer patients.

Secondary audiences include primary care physicians, family physicians, nurses, physician assistants, and pharmacists.

FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES

It is the policy of the Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).  Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.  Detailed disclosure will be made in the course handout materials.

Conferences and events that once met in hotels and convention centers now meet live online. Why? Because live online events provide global reach, convenient online access to live video content featuring key opinion leaders, real-time networking with presenters and peers, and the efficient use of time and resources for attendees and supporters.
PlatformQ is the leading producer of live online events for audiences from 500 to 50,000. PlatformQ brings attendees, thought leaders, and product and service providers together in engaging interactive environments. PlatformQ provide marketers with measurable, targeted, and contextual environments for audience education and engagement. The result: more qualified leads, in less time, at lower cost. To learn more, visit www.PlatformQ.com.

Tags: